SciFi Futures
← Concepts
Biotech & Medicine

Human reproductive cloning

Producing a genetically identical human being from the cell of an existing person, deliberately and at scale.

In shortHuman reproductive cloning, from Never Let Me Go (Kazuo Ishiguro, 2005) and The Boys from Brazil (Ira Levin, 1976), is at technology readiness level 3 of 9 (experimental proof of concept) at its weakest link. Held back by Reconstructed implantation and placentation and In vitro gametogenesis. Science status: underlying science well understood; an engineering problem. Estimated new funding to unlock: $1.5B–5.8B.

Kathy, Tommy and Ruth are clones raised in institutions to provide organs, donating until they complete, with the cloning programme's existence politically tolerated and socially hidden.
Never Let Me Go by Kazuo Ishiguro, 2005Set in 1999Overdue27 years past the story's date; weakest link still at TRL 3
Mengele implants 94 embryos cloned from Hitler's tissue into surrogate mothers and engineers matching childhoods, assuming genotype plus environment will reproduce the man.
The Boys from Brazil by Ira Levin, 1976Set in 1975Overdue51 years past the story's date; weakest link still at TRL 3

Closest todayCloning is routine in livestock and produced one rhesus monkey that reached adulthood in 2024 using trophoblast replacement; human SCNT embryos were made in 2025 but under 9 percent reached blastocyst and most were chromosomally abnormal.

Dependency stack

Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
  • Cloned primate embryos fail mainly at implantation and placentation, which is where the biology is unknown
    • The placenta's endocrine and nutrient-exchange functions have not been reproduced by any device or culture
    • Maternal immune tolerance at the interface is not understood well enough to substitute for
    • Human implantation cannot be studied past the 14-day limit, so the critical window is inaccessible
    TRL 3
  • The whole procedure is nuclear transfer, and in primates it works at a few percent with placental defects
    ✕3 blockers›
    • Incomplete epigenetic reprogramming of the donor nucleus produces placental defects and large-offspring syndrome
    • Efficiency is a few percent of transferred embryos, so each live birth consumes many donor eggs and surrogates
    • Donor egg supply is the limiting input for any primate-scale program
    TRL 5
  • majorIn vitro gametogenesisbottleneck
    Donor oocytes are the limiting input, and each attempt consumes many
    • Human oocyte maturation needs months of follicle growth that culture cannot yet sustain
    • Meiotic recombination and chromosome segregation are error-prone outside the ovary, giving aneuploidy
    • Imprinting marks are set during germ-cell development and are mis-set in vitro, with no safety assay short of a live birth
    TRL 3
  • Clones inherit the donor cell's epigenetic and telomeric age, which must be reset for a normal lifespan
    ✕3 blockers›
    • No validated surrogate biomarker of biological age, so any whole-body rejuvenation claim needs decade-long outcome trials
    • Hallmarks of aging are correlated; interventions cannot yet be attributed to a specific causal node
    • Mouse lifespan results have repeatedly failed to transfer to longer-lived species
    TRL 3

Who could unlock it

Reconstructed implantation and placentationTRL 3bottleneck
  • Jacob HannaResearcher, Weizmann Institute of Science
    Built the ex utero mouse embryo culture platform (Nature, 2021) that the 2026 extension into the fetal period is based on
  • Nicolas RivronResearcher, Institute of Molecular Biotechnology, Austrian Academy of Sciences
    Makes human blastoids that attach to hormonally primed endometrial organoids, and used the assay to screen compounds that block implantation
  • Ashley MoffettResearcher, University of Cambridge
    Showed uterine natural killer cells control extravillous trophoblast differentiation in early pregnancy (Cell Stem Cell, 2024), the core of maternal immune tolerance
  • Centre for Trophoblast ResearchAcademic lab
    Cambridge centre supplying the trophoblast organoid and placental-interface biology the rest of the field builds on
In vitro gametogenesisTRL 3bottleneck
  • Conception BiosciencesStartup
    Reported the first stem-cell-derived human primary oocytes inside entirely iPSC-derived follicle structures, from a blood draw (June 2026)
  • Katsuhiko HayashiResearcher, Osaka University
    Produced healthy fertile mouse pups from iPSC-derived eggs (2016), the only complete mammalian IVG demonstration, and collaborates with Conception
  • Mitinori SaitouResearcher, ASHBi, Kyoto University
    Generated human oogonia from iPSCs (Science, 2018) and reconstituted human germline epigenetic reprogramming in vitro (Nature, 2024), defining the steps the field has to reproduce
  • GametoStartup
    Its iPSC-derived ovarian support cell product Fertilo produced the first live birth from stem-cell-assisted egg maturation (December 2024) and is in Phase 3 after a $44M Series C in August 2025
Somatic cell nuclear transfer cloningTRL 5
  • Qiang SunResearcher, Institute of Neuroscience, Chinese Academy of Sciences
    Cloned the macaques Zhong Zhong and Hua Hua (2018) and ReTro, the first cloned rhesus to reach adulthood, using trophoblast replacement (2024)
  • Institute of Neuroscience, Chinese Academy of SciencesGovernment lab
    The only group to have produced primate clones; its 2024 result consumed 113 transferred embryos for one surviving animal
  • ViaGen Pets and EquineCompany
    The commercial SCNT operation, cloning cats, dogs and horses and the Przewalski's horse Kurt; acquired by Colossal Biosciences in November 2025
  • Colossal BiosciencesStartup
    Uses cloning from edited cell lines as its route to live animals and bought ViaGen in 2025 to bring that throughput in-house

Beyond engineering

  • Reproductive cloning is banned outright in most countries
  • Legal parentage, identity and rights of a cloned person are undefined
  • Both novels turn on treating clones as a resource rather than as people, which is the actual governing risk